	Real-world comparative outcomes of darolutamide- versus abiraterone-based triplet therapy for metastatic hormone-sensitive prostate cancer: a retrospective cohort study. Ther Adv Urol Chen IA, Chang RI, Yu CC, Lin TP, Yang CY. PMID: 42405379 [PubMed - in process]
	Tumor suppressor network dysregulation in neuroblastoma: molecular mechanisms and precision therapeutic opportunities. Front Cell Dev Biol Gupta R, Lakhanpal S, Kumar N, Nagraik R, Ravi K, Sharma S, Abomughaid MM, Kumari S, Jha NK. PMID: 42405329 [PubMed - in process]
	Cancer-related mortality among solid organ transplant recipients: systematic review and meta-analysis. Front Transplant Stephens C, Shah R, Hussain A, Sturman J, Zhang Y, Baldwin F, Winter D, Hawkins M, Reulen R, Sharif A. PMID: 42405264 [PubMed - in process]
	A retrospective study of differential prognostic factors in early-onset versus late-onset colorectal cancer: a comprehensive clinical and machine learning analysis. PeerJ Huang L, Zhong R, Li K, Chen J, He Y, Ye Y, Chen S, Wei Q, Mai H, Zhang Y, Wang Z. PMID: 42405254 [PubMed - in process]
	Fuscan: a robust DNA fusion caller for targeted sequencing data in cancer diagnostics. Bioinform Adv Liu Z, Wang S, Chen S, Feng H, Hu X, Zhou P, Shi D. PMID: 42405191 [PubMed - in process]
	Review on drug repositioning of some FDA-approved drugs for treatment of cancer/microbial diseases. RSC Adv Ismail MMF, Shawer TZ, ElBakry OM, Baumy EAA, Eissa SI. PMID: 42405136 [PubMed - as supplied by publisher]
	Advances in the design and discovery of small-molecule tyrosine kinase inhibitors for breast cancer. RSC Adv Elwaie TA, Aref MMA, Ali HI. PMID: 42405118 [PubMed - as supplied by publisher]
	Copper-based metal-organic frameworks: applications and prospects in cancer diagnosis and therapy. RSC Adv Huang Y, Zhu J, Guan A, Qing W. PMID: 42405084 [PubMed - as supplied by publisher]
	Zeylenone-mediated inhibition of TIMP-1-induced Bax/Bcl-2/Cle-caspase-3 expression and apoptosis via FAK-PI3K/AKT pathway regulation in thyroid cancer cells: in vitro and in silico study. 3 Biotech Qin S, Zhou J, Wu X, Jiang L. PMID: 42404973 [PubMed - in process]
	Correction: Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study). Front Immunol Omar NE, Elazzazy S, Hamad A, Saad MO, Alasmar A, Nasser SM, Benkhadra M, Afifi HM, Jibril FI, Dawoud RA, Hamid MS, Alnajjar A, Sahal AO, Gulied A, Elewa H. PMID: 42404898 [PubMed - in process]
	Neuro-immune interactions in cancer: mechanisms and therapeutic prospects. Front Immunol Liu J, Zhang C, Zhang C, Pei J, Li Y. PMID: 42404893 [PubMed - in process]
	Neural regulation of tumor progression: implications for hepatocellular carcinoma. Front Immunol Chen Y, Long Z, Zang YS, Wu D. PMID: 42404890 [PubMed - in process]
	The lactylation axis: bridging metabolic reprogramming and immunosuppression in the tumor microenvironment. Front Immunol Tao X, Liu Y, Yu P, Wu W, Fu Y, Lan P, Jin S. PMID: 42404889 [PubMed - in process]
	Radiomics and Deep Learning: Bridging Breast Cancer Imaging Phenotypes and Genomic Heterogeneity. Breast Cancer (Dove Med Press) Yi G, Deng L, Su L, Jie H, Huang C, Wang Y. PMID: 42404859 [PubMed - in process]
	Intratumoral microbiome: a key regulator and novel therapeutic target for chemoresistance in pancreatic cancer. Front Cell Infect Microbiol Wang Y, Wu J. PMID: 42404769 [PubMed - in process]
	Construction of an ultrasound feature-based diagnostic model for predicting triple-negative breast cancer using 108 machine learning algorithm combinations. J Clin Imaging Sci Zhang X, Zhang X, Zhu S, Ao N, Cao Y, Yang G. PMID: 42404642 [PubMed - in process]
	Next-Generation CDK Inhibitors in Breast Cancer: Expanding the Therapeutic Landscape beyond CDK4/6 Inhibitors. Breast Care (Basel) Wu J, Lai Y, Lu G. PMID: 42404635 [PubMed - as supplied by publisher]
	Nanomedicine targeting ECM stiffness: restoring mechanical homeostasis for cancer immunotherapy. Mater Today Bio Yang M, Jia H, Zhang Y, Shen X, Zhang Y, Liu Y, Jia X, Yu C, Liu Z. PMID: 42404626 [PubMed - in process]
	SCC-Net: A lightweight attention-enhanced deep learning model for automated squamous cell carcinoma detection. Digit Health Wu Y, Li X, Zhao M. PMID: 42404593 [PubMed - in process]
	Development and Validation of a Pathomics Model for Prognosis Prediction in Neoadjuvant Therapy-Treated Breast Cancer: A Retrospective, Multicenter Study. MedComm (2020) Wei Y, Lou W, Han Z, Yang F, Li F, Li H, Shi H, Wei B, Li H, Zhao Y, Xiao X, Yang Y, Han A, Yao J, Bu H. PMID: 42404588 [PubMed - in process]

Articles 1 - 20 / 1952562

Page 1 of 97629



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy